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Bid is an unusual BH3-only protein because it can be activated through proteolytic cleavage by caspases or certain other proteases (e.g. granzyme B). For example, during Fas (APO-1/CD95)-induced apoptosis signalling, full-length (relatively poorly active) Bid (p22) is processed by caspase-8 into the potently proapoptotic, truncated tBid (p15), which translocates to the outer mitochondrial membrane where it promotes the release of apoptogenic molecules, such as cytochrome c, and amplification of the caspase cascade. 2, 3 Experiments with gene-targeted mice have shown that Bid is essential for anti-Fas antibody-induced apoptosis of hepatocytes in vivo. 4 These mice had a mixed genetic background and retained a strong promoter (from the drug selection cassette) within the targeted locus, which can cause nonspecific effects owing to influences on expression of neighbouring genes. To obviate such potential problems, we have generated a new bid À/À mouse strain on a pure C57BL/6 genetic background and have removed the drug selection cassette and its strong promoter by Cre-mediated recombination (TK and AS, submitted). We confirmed that Bid is essential for anti-Fas antibody-induced fatal hepatitis and could also show that Bid is required for hepatocyte apoptosis induced by the more physiological recombinant FasL (TK and AS, submitted). This is an important finding because anti-Fas antibodies do not always reliably mimic the action of the physiological ligand. 5 The role of Bid in TNF-TNF-R-mediated cell killing is, however, presently still unresolved.
In addition to the proapoptotic signalling pathway, ligation of TNF-R1 on hepatocytes and certain other cell types (e.g. fibroblasts) also triggers potent prosurvival as well as differentiation-and proliferation-inducing pathways. 6, 7 This involves, at least in part, activation of NF-kB transcription factors, such as p65/RelA and, accordingly, TNF-mediated apoptosis of fibroblasts is strongly enhanced by blocking this transcription-dependent, prosurvival pathway. 8, 9 In a wellestablished genetic mouse model, loss of p65/RelA leads to embryonic lethality around E15 owing to massive hepatocyte apoptosis. 10 This death can be prevented by concomitant loss of TNF or TNF-R1, demonstrating that it is triggered by the TNF-TNF-R1 cell killing pathway. 11, 12 We have recently found that overexpression of Bcl-2 in hepatocytes under control of the liver-specific a-anti-trypsin (AAT) promoter is unable to prevent or even delay the fatal hepatocyte death in embryos lacking RelA. 13 This may indicate that proapoptotic BH3-only proteins, such as Bid, are not critical for TNF-TNF-R1-induced apoptosis in hepatocytes. However, binding studies have indicated that Bcl-2 might not be the optimal neutralising interaction partner for truncated Bid (tBid), with the Bcl-2 homologues Bcl-x L and Bcl-w having much higher binding affinities for tBid.
14 Consistent with the notion that Bcl-2 is a poor antagonist of Bid, bid À/À mice, 4 but not the AAT-bcl-2 transgenic mice ( In order to clarify this issue and to examine the importance of Bid in TNF-TNF-R1 cell death signalling, we intercrossed bid À/À with rela À/À mice. Strikingly, the absence of Bid failed to rescue RelA-deficient embryos from death, as no viable bid À/À rela À/À mice were observed among 182 offspring resulting from bid À/À rela þ /À intercrosses ( Figure 1a) . Moreover, at E14.5, as well as at E15.5 bid À/À rela À/À embryos showed a comparable extent of liver destruction and haemorrhaging as seen in control bid þ / þ rela À/À embryos (Figure 1b and c; see also Gugasyan et al 13 ). These results demonstrate that, in contrast to Fas-induced apoptosis, Bid is not essential for TNF-TNF-R1 signalling-mediated hepatocyte killing during embryonic development, at least within the context of RelAdeficiency.
Collectively, our results demonstrate that the proapoptotic FasL-Fas pathway differs from the TNF-TNF-R1 cell killing pathway, at least in mouse hepatocytes. Whereas Fasmediated apoptosis requires the BH3-only protein Bid, loss of Bid failed to prevent TNF-TNF-R1-mediated hepatocyte killing in RelA-deficient embryos. Hence, TNF-R1 must trigger cell death through components other than or in addition to Bid. Although differences between foetal and adult hepatocytes cannot be excluded, it is noteworthy that we found that adult bid À/À mice are normally sensitive to TNF-mediated hepatocyte destruction (TK and AS, submitted). Moreover, although it is theoretically possible that non-apoptotic, caspase-independent processes mediate TNF-induced hepatocyte killing, as described in certain other cell types, 7, 15 loss of caspase-8 in hepatocytes protected mice against TNFmediated hepatitis (TK and AS, submitted). We therefore assume that TNF-TNF-R1 signalling kills RelA-deficient hepatocytes by caspase-dependent apoptosis. It is possible that TNF-R1 ligation stimulates levels of caspase-8 activity sufficient to trigger hepatocyte destruction, whereas Fas signalling elicits only relatively low levels of caspase-8 activity, therefore needing Bid-mediated amplification of the caspase cascade to kill cells. This hypothesis can be tested by generating RelA-deficient mice lacking caspase-8 selectively in hepatocytes. It is also possible that TNF-R1 stimulation causes activation of BH3-only proteins or other proapoptotic factors in addition to Bid. Bim is a possible candidate, because it was reported to be activated in response to phosphorylation by JNK, 16 a kinase that is stimulated during TNF-R1 signalling. 6 Moreover, caspase-mediated proteolysis has been shown to enhance the proapoptotic activity of Bim EL , 17 the most highly expressed isoform of Bim in the liver, 18, 19 thereby creating an amplification of the apoptotic signalling cascade similar to the one involving Bid. It will therefore be interesting to test whether combined loss of Bid and Bim can prevent the fatal hepatocyte destruction in RelA-deficient embryos. The generation of Bid-deficient mice is described elsewhere (TK and AS, submitted). The rela À/À mice were originally generated on a mixed C57BL/6x129SV background using 129SV-derived ES cells 10 but had been backcrossed with C57BL/6 mice for 49 generations before intercrossing with our bid À/À mice. All experiments with mice were carried out according to the guidelines of the animal ethics committees of the Melbourne Health Research Directorate
